Cargando…

Optimization of culture conditions for rapid clinical-scale expansion of human umbilical cord blood-derived mesenchymal stem cells

BACKGROUND: Mesenchymal stem cells (MSCs) have broad-spectrum therapeutic effects in various diseases, and thus have many clinical applications. However, it is difficult to produce sufficient numbers of MSCs for clinical use, and improved culture systems are required. Here, we report the effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Wankyu, Kwon, Soon-Jae, Jin, Hye Jin, Jeong, Sang Young, Choi, Soo Jin, Oh, Wonil, Yang, Yoon Sun, Jeon, Hong Bae, Jeon, Eun Su
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634990/
https://www.ncbi.nlm.nih.gov/pubmed/29019171
http://dx.doi.org/10.1186/s40169-017-0168-z
_version_ 1783270190739357696
author Choi, Wankyu
Kwon, Soon-Jae
Jin, Hye Jin
Jeong, Sang Young
Choi, Soo Jin
Oh, Wonil
Yang, Yoon Sun
Jeon, Hong Bae
Jeon, Eun Su
author_facet Choi, Wankyu
Kwon, Soon-Jae
Jin, Hye Jin
Jeong, Sang Young
Choi, Soo Jin
Oh, Wonil
Yang, Yoon Sun
Jeon, Hong Bae
Jeon, Eun Su
author_sort Choi, Wankyu
collection PubMed
description BACKGROUND: Mesenchymal stem cells (MSCs) have broad-spectrum therapeutic effects in various diseases, and thus have many clinical applications. However, it is difficult to produce sufficient numbers of MSCs for clinical use, and improved culture systems are required. Here, we report the effects of calcium (Ca(2+)) and hypoxia on the proliferation of human umbilical cord blood-derived MSCs (hUCB-MSCs). In addition, we determined the optimal conditions of these two factors for the large-scale culture of hUCB-MSCs. METHODS: hUCB-MSCs were maintained under hypoxic conditions (3% O(2)) with 1.8 mM Ca(2+) during long-term culture, and their proliferation was evaluated. To characterize the underlying mechanisms, the effects on hypoxia-inducible factor (HIF)-1α and the extracellular signal-regulated kinase (ERK) signaling pathways were investigated. The therapeutic effects in a mouse emphysema model were analyzed and compared with those of naive MSCs. RESULTS: The proliferation of Ca(2+)/hypoxia-treated hUCB-MSCs was increased compared with that observed using either calcium or hypoxia culture alone, without loss of stem cell marker expression or differentiation ability. The enhancement of the proliferation capacity of hUCB-MSCs by the synergistic effects of Ca(2+) and hypoxia was dependent on the expression of HIF-1α and the ERK signaling pathway. The proliferation of Ca(2+)/hypoxia-treated hUCB-MSCs resulted in a delayed senescence phenotype and increased the expression levels of stemness genes such as Oct4 and Nanog compared to those observed in conventional culture conditions. In addition, Ca(2+)/hypoxia-treated MSCs transplantation in the mouse emphysema model showed the same therapeutic effects as observed with naive MSCs. CONCLUSIONS: These findings suggest that a Ca(2+)/hypoxia-based expansion system has applications for the large-scale production of MSCs for therapeutic purposes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40169-017-0168-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5634990
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-56349902017-10-24 Optimization of culture conditions for rapid clinical-scale expansion of human umbilical cord blood-derived mesenchymal stem cells Choi, Wankyu Kwon, Soon-Jae Jin, Hye Jin Jeong, Sang Young Choi, Soo Jin Oh, Wonil Yang, Yoon Sun Jeon, Hong Bae Jeon, Eun Su Clin Transl Med Research BACKGROUND: Mesenchymal stem cells (MSCs) have broad-spectrum therapeutic effects in various diseases, and thus have many clinical applications. However, it is difficult to produce sufficient numbers of MSCs for clinical use, and improved culture systems are required. Here, we report the effects of calcium (Ca(2+)) and hypoxia on the proliferation of human umbilical cord blood-derived MSCs (hUCB-MSCs). In addition, we determined the optimal conditions of these two factors for the large-scale culture of hUCB-MSCs. METHODS: hUCB-MSCs were maintained under hypoxic conditions (3% O(2)) with 1.8 mM Ca(2+) during long-term culture, and their proliferation was evaluated. To characterize the underlying mechanisms, the effects on hypoxia-inducible factor (HIF)-1α and the extracellular signal-regulated kinase (ERK) signaling pathways were investigated. The therapeutic effects in a mouse emphysema model were analyzed and compared with those of naive MSCs. RESULTS: The proliferation of Ca(2+)/hypoxia-treated hUCB-MSCs was increased compared with that observed using either calcium or hypoxia culture alone, without loss of stem cell marker expression or differentiation ability. The enhancement of the proliferation capacity of hUCB-MSCs by the synergistic effects of Ca(2+) and hypoxia was dependent on the expression of HIF-1α and the ERK signaling pathway. The proliferation of Ca(2+)/hypoxia-treated hUCB-MSCs resulted in a delayed senescence phenotype and increased the expression levels of stemness genes such as Oct4 and Nanog compared to those observed in conventional culture conditions. In addition, Ca(2+)/hypoxia-treated MSCs transplantation in the mouse emphysema model showed the same therapeutic effects as observed with naive MSCs. CONCLUSIONS: These findings suggest that a Ca(2+)/hypoxia-based expansion system has applications for the large-scale production of MSCs for therapeutic purposes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40169-017-0168-z) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-10-10 /pmc/articles/PMC5634990/ /pubmed/29019171 http://dx.doi.org/10.1186/s40169-017-0168-z Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Choi, Wankyu
Kwon, Soon-Jae
Jin, Hye Jin
Jeong, Sang Young
Choi, Soo Jin
Oh, Wonil
Yang, Yoon Sun
Jeon, Hong Bae
Jeon, Eun Su
Optimization of culture conditions for rapid clinical-scale expansion of human umbilical cord blood-derived mesenchymal stem cells
title Optimization of culture conditions for rapid clinical-scale expansion of human umbilical cord blood-derived mesenchymal stem cells
title_full Optimization of culture conditions for rapid clinical-scale expansion of human umbilical cord blood-derived mesenchymal stem cells
title_fullStr Optimization of culture conditions for rapid clinical-scale expansion of human umbilical cord blood-derived mesenchymal stem cells
title_full_unstemmed Optimization of culture conditions for rapid clinical-scale expansion of human umbilical cord blood-derived mesenchymal stem cells
title_short Optimization of culture conditions for rapid clinical-scale expansion of human umbilical cord blood-derived mesenchymal stem cells
title_sort optimization of culture conditions for rapid clinical-scale expansion of human umbilical cord blood-derived mesenchymal stem cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634990/
https://www.ncbi.nlm.nih.gov/pubmed/29019171
http://dx.doi.org/10.1186/s40169-017-0168-z
work_keys_str_mv AT choiwankyu optimizationofcultureconditionsforrapidclinicalscaleexpansionofhumanumbilicalcordbloodderivedmesenchymalstemcells
AT kwonsoonjae optimizationofcultureconditionsforrapidclinicalscaleexpansionofhumanumbilicalcordbloodderivedmesenchymalstemcells
AT jinhyejin optimizationofcultureconditionsforrapidclinicalscaleexpansionofhumanumbilicalcordbloodderivedmesenchymalstemcells
AT jeongsangyoung optimizationofcultureconditionsforrapidclinicalscaleexpansionofhumanumbilicalcordbloodderivedmesenchymalstemcells
AT choisoojin optimizationofcultureconditionsforrapidclinicalscaleexpansionofhumanumbilicalcordbloodderivedmesenchymalstemcells
AT ohwonil optimizationofcultureconditionsforrapidclinicalscaleexpansionofhumanumbilicalcordbloodderivedmesenchymalstemcells
AT yangyoonsun optimizationofcultureconditionsforrapidclinicalscaleexpansionofhumanumbilicalcordbloodderivedmesenchymalstemcells
AT jeonhongbae optimizationofcultureconditionsforrapidclinicalscaleexpansionofhumanumbilicalcordbloodderivedmesenchymalstemcells
AT jeoneunsu optimizationofcultureconditionsforrapidclinicalscaleexpansionofhumanumbilicalcordbloodderivedmesenchymalstemcells